NINEVAH THERAPEUTICS LTD

Unknown (Unknown)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£342,713

Nov 21 - Apr 23

Novel gene therapy platform for monogenic kidney diseases developed in the context of Alport Syndrome

Innovate UK award to NINEVAH THERAPEUTICS LTD and Marc Ramis Castelltort

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}